Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Pharmacogenomics J ; 12(4): 287-96, 2012 Aug.
Article in English | MEDLINE | ID: mdl-21358749

ABSTRACT

UGT2B enzymes metabolize multiple endogenous and exogenous molecules, including steroid hormones and clinical drugs. However, little is known about the inter-individual variation in gene expression and its determinants. We re-sequenced candidate regulatory regions and the partial coding regions (41.1 kb) of UGT2B genes and identified 332 genetic variants. We measured gene expression in normal breast and liver samples and observed different patterns. The expression levels varied greatly across individuals in both tissues and were significantly correlated with each other in liver. Genotyping of tagging single-nucleotide polymorphisms (SNPs) in the same samples and association tests between genotype and transcript levels identified 62 variants that were associated with at least one UGT2B mRNA levels in either tissue. Most of these cis-regulatory SNPs were not shared between tissues, suggesting that this gene family is regulated in a tissue-specific manner. Our results provide insight into studying the role of UGT2B variation in hormone-dependent cancers and drug response.


Subject(s)
Glucuronosyltransferase/genetics , Breast/metabolism , Female , Gene Expression Profiling , Humans , Liver/metabolism , Male , Polymorphism, Single Nucleotide , RNA, Messenger/metabolism , Regulatory Sequences, Nucleic Acid/genetics
2.
Pharmacogenomics J ; 6(1): 52-62, 2006.
Article in English | MEDLINE | ID: mdl-16314881

ABSTRACT

Common polymorphisms within the human UGT1A gene locus are associated with irinotecan and tranilast toxicity. To uncover additional functional variation across this gene cluster, cross-species sequence comparisons were performed. Evolutionarily conserved segments (a total of 47.1 kb) were re-sequenced in 24 African-American, 24 European-American, and 24 Asian individuals, and 381 segregating sites (including 123 singletons) were identified. Highly conserved coding sites were less likely to be polymorphic than diverged sites (P<0.0001) but this pattern was not observed at non-coding sites (P=0.1025). Among coding variants, the distribution of those computationally predicted to affect function was skewed toward low frequencies. Some alleles occurred at similar frequencies in each population; others had wide disparities. Although strong linkage disequilibrium was detected among the hepatically expressed genes, the degree of linkage disequilibrium varied among populations. These results suggest that rare functional gene variants and inter-population variability must be considered in the interpretation of association studies between UGT1A and drug metabolism/toxicity phenotypes.


Subject(s)
Genetic Variation , Glucuronosyltransferase/genetics , Multigene Family , Animals , Asian People/genetics , Base Sequence , Black People/genetics , Dogs , Gene Frequency , Humans , Mice , Molecular Sequence Data , Papio , Rats , Sequence Alignment , Species Specificity , White People/genetics
3.
Am J Hum Genet ; 75(6): 1059-69, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15492926

ABSTRACT

Members of the cytochrome P450 3A subfamily catalyze the metabolism of endogenous substrates, environmental carcinogens, and clinically important exogenous compounds, such as prescription drugs and therapeutic agents. In particular, the CYP3A4 and CYP3A5 genes play an especially important role in pharmacogenetics, since they metabolize >50% of the drugs on the market. However, known genetic variants at these two loci are not sufficient to account for the observed phenotypic variability in drug response. We used a comparative genomics approach to identify conserved coding and noncoding regions at these genes and resequenced them in three ethnically diverse human populations. We show that remarkable interpopulation differences exist with regard to frequency spectrum and haplotype structure. The non-African samples are characterized by a marked excess of rare variants and the presence of a homogeneous group of long-range haplotypes at high frequency. The CYP3A5*1/*3 polymorphism, which is likely to influence salt and water retention and risk for salt-sensitive hypertension, was genotyped in >1,000 individuals from 52 worldwide population samples. The results reveal an unusual geographic pattern whereby the CYP3A5*3 frequency shows extreme variation across human populations and is significantly correlated with distance from the equator. Furthermore, we show that an unlinked variant, AGT M235T, previously implicated in hypertension and pre-eclampsia, exhibits a similar geographic distribution and is significantly correlated in frequency with CYP3A5*1/*3. Taken together, these results suggest that variants that influence salt homeostasis were the targets of a shared selective pressure that resulted from an environmental variable correlated with latitude.


Subject(s)
Cytochrome P-450 Enzyme System/genetics , Evolution, Molecular , Genetic Variation , Water-Electrolyte Balance/genetics , Black or African American/genetics , Asian/genetics , Base Sequence , Binding Sites , Conserved Sequence/genetics , Cytochrome P-450 CYP3A , DNA Primers , Gene Frequency , Genomics/methods , Geography , Haplotypes/genetics , Humans , Los Angeles , Molecular Sequence Data , Polymorphism, Single Nucleotide/genetics , Sequence Analysis, DNA , Sodium Chloride/metabolism , Transcription Factors/metabolism , White People/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...